These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7107623)

  • 1. Photolabeling of a hydrophobic domain of the ninth component of human complement.
    Ishida B; Wisnieski BJ; Lavine CH; Esser AF
    J Biol Chem; 1982 Sep; 257(18):10551-3. PubMed ID: 7107623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An amphiphilic structure of the ninth component of human complement. Evidence from analysis of fragments produced by alpha-thrombin.
    Biesecker G; Gerard C; Hugli TE
    J Biol Chem; 1982 Mar; 257(5):2584-90. PubMed ID: 6460761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: participation of two separate epitopes of C9 in C5b-8 binding.
    Hatanaka M; Seya T; Yoden A; Fukamoto K; Semba T; Inai S
    Mol Immunol; 1992; 29(7-8):911-6. PubMed ID: 1378934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
    Ninomiya H; Sims PJ
    J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the C9b domain in the binding of C9 molecules to EAC1-8 defined by monoclonal antibodies to C9.
    Yoden A; Moriyama T; Inoue K; Inai S
    J Immunol; 1988 Apr; 140(7):2317-21. PubMed ID: 3351301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The membrane attack complex of complement: lipid insertion of tubular and nontubular polymerized C9.
    Amiguet P; Brunner J; Tschopp J
    Biochemistry; 1985 Dec; 24(25):7328-34. PubMed ID: 4084584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ninth component of human complement (C9). Functional activity of the b fragment.
    Shiver JW; Dankert JR; Donovan JJ; Esser AF
    J Biol Chem; 1986 Jul; 261(21):9629-36. PubMed ID: 2426252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R; Deppisch R; Rauterberg EW
    Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identity of a peptide domain of human C9 that is bound by the cell-surface complement inhibitor, CD59.
    Chang CP; Hüsler T; Zhao J; Wiedmer T; Sims PJ
    J Biol Chem; 1994 Oct; 269(42):26424-30. PubMed ID: 7523406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The architecture of complement component C9 and poly(C9).
    DiScipio RG; Hugli TE
    J Biol Chem; 1985 Nov; 260(27):14802-9. PubMed ID: 4055801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-catalyzed disulfide-linking of C9 in the membrane attack complex of complement.
    Yamamoto K; Kawashima T; Migita S
    J Biol Chem; 1982 Aug; 257(15):8573-6. PubMed ID: 7096325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of the C9b fragment of human complement component C9 using urea in the absence of detergents.
    Gu X; Dankert JR
    J Immunol Methods; 1996 Jan; 189(1):37-45. PubMed ID: 8576578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the association of the eighth and ninth components of human complement within the membrane-bound cytolytic complex.
    Monahan JB; Stewart JL; Sodetz JM
    J Biol Chem; 1983 Apr; 258(8):5056-62. PubMed ID: 6833292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER; Preissner KT; Müller-Eberhard HJ
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ
    Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI; Packman CH; Leddy JP
    J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane permeability to macromolecules mediated by the membrane attack complex.
    Malinski JA; Nelsestuen GL
    Biochemistry; 1989 Jan; 28(1):61-70. PubMed ID: 2706268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA; Sims PJ
    J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J; Chonn A; Hertig S; French LE
    J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.